Albert Bourla, Pfizer CEO (Gian Ehrenzeller/Keystone via AP Images)

Up­dat­ing the Covid-19 vac­cine: FDA of­fers a qual­i­fied thumbs-up ahead of ad­comm

The FDA’s ad­comm of out­side vac­cine ex­perts will meet to­mor­row to dis­cuss how to pro­tect the US from a like­ly com­ing wave of Omi­cron cas­es in the fall and win­ter, and whether to de­ploy vac­cines that specif­i­cal­ly tar­get the Omi­cron vari­ant.

While the da­ta so far are lim­it­ed, the FDA sound­ed an up­beat tone in the brief­ing doc­u­ments on Pfiz­er/BioN­Tech’s can­di­dates, re­leased this week­end ahead of the VRB­PAC meet­ing.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.